Sound Pharmaceuticals has concluded subject enrolment for its second Phase III clinical trial assessing SPI-1005 in adults with probable or...
Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device...
Innovent Biologics has granted Spero Therapeutics an exclusive licence deal to develop and commercialise IBI355 outside Greater China.The post Innovent...
Claria Medical has secured De Novo classification and marketing authorisation from the US FDA for its Claria System, a device...
Ionis Pharmaceuticals has dosed the first participant in its Phase I-II ASCEND trial evaluating ION337 for children with Dravet syndrome.The...
Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle...
Virax Biolabs (UK) has signed an exclusive commercial supply agreement with Fosun Diagnostics for its research-use-only ImmuneSelect immune profiling product...
Novo Nordisk has reported positive results from the ongoing Phase III FRONTIER4 extension trial, assessing the long-term safety and efficacy...
The FDA has approved two of MSD's anti-PD-1 therapies, Keytruda and Keytruda Qlex, along with Padcev, for adults with MIBC.The...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.